REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
03/10/2025
Back to search
Official data from USPTO
DENKI
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
45
Latest update
03/10/2025
Trademark type
Word
Nice classes
1, 42
Filing date
01/15/2019
Registration date
03/10/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/10/2020
Last transaction
03/10/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
F-75013 PARIS, FR
Examiner
STEDMAN, CORI
Law office
N50
Current location
POST REGISTRATION
Holders and representatives
Holders
PHARMALEADS
PHARMALEADS
Representatives
Dianne M. Smith-Misemer HOVEY WILLIAMS LLP
Technical classification
Nice Classes
Class 1Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemical products for use in industry and scienceall aforementioned goods only for dual enkephalinase inhibitors * all the aforesaid goods exclusively in connection with dual enkephalinase inhibitors *
Class 42
scientific technological services namelyscientific researchanalysistesting in the field of endogenous opioid peptides; scientific research and design and development services related to the inhibition of the degradation of endogenous opioid peptidesall in the medical and pharmaceutical fields; development of medicines for others * third parties * ; medicine discovery services in the nature of development of pharmaceutical preparationsall aforementioned services only for dual enkephalinase inhibitors * all the aforesaid services exclusively in connection with dual enkephalinase inhibitors *
Publications
History of USPTO decisions and trademark events.
45 publications found
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
07/21/2021
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
07/10/2021
INNA
INVALIDATION REVIEWED - NO ACTION REQUIRED BY OFFICE
01/05/2021
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
01/04/2021
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
08/07/2020
FICS
FINAL DISPOSITION NOTICE SENT TO IB
07/20/2020
FIMP
FINAL DISPOSITION PROCESSED
07/20/2020
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/10/2020
LIME
LIMITATION FROM THE IB EXAMINED AND ENTERED
04/24/2020
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
04/23/2020
PLGL
ASSIGNED TO PARALEGAL
04/23/2020
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
03/20/2020
R.PR
REGISTERED-PRINCIPAL REGISTER
03/10/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
02/04/2020
LIMN
LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
01/22/2020
GPNX
NOTIFICATION PROCESSED BY IB
01/03/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/24/2019
PUBO
PUBLISHED FOR OPPOSITION
12/24/2019
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
12/18/2019
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
12/18/2019
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/04/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/29/2019
LIMG
LIMITATION OF GOODS RECEIVED FROM IB
11/22/2019
ALIE
ASSIGNED TO LIE
11/15/2019
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/13/2019
XAEC
EXAMINER'S AMENDMENT ENTERED
11/13/2019
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11/13/2019
GNEA
EXAMINERS AMENDMENT E-MAILED
11/13/2019
CNEA
EXAMINERS AMENDMENT -WRITTEN
11/13/2019
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/24/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/24/2019
RFNP
REFUSAL PROCESSED BY IB
05/18/2019
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
05/02/2019
RFRR
REFUSAL PROCESSED BY MPU
05/02/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
04/10/2019
CNRT
NON-FINAL ACTION WRITTEN
04/09/2019
RFWR
NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW
04/08/2019
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/28/2019
CNRT
NON-FINAL ACTION WRITTEN
03/27/2019
DOCK
ASSIGNED TO EXAMINER
03/27/2019
MAFR
APPLICATION FILING RECEIPT MAILED
03/05/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
02/27/2019
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
02/21/2019
Continuous trademark protection
Get notified about every new filing that threatens DENKI or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.